Shanghai Bio-Heart Biological Technology Co., Ltd. Class H (2185) Stock Statistics & Valuation Metrics

Shanghai Bio-Heart Biological Technology Co., Ltd. Class H has a market cap or net worth of HKD 226.38M. The enterprise value is HKD 734.25M.

Market Cap

HKD 226.38M

Enterprise Value

HKD 734.25M

Shanghai Bio-Heart Biological Technology Co., Ltd. Class H has 235,703,410 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

235,703,410

Owned by Insiders

―

Owned by Institutions

0.04%

Shanghai Bio-Heart Biological Technology Co., Ltd. Class H’s return on equity (ROE) is -0.16 and return on invested capital (ROIC) is -6.15%.

Return on Equity (ROE)

-0.16

Return on Assets (ROA)

-0.08

Return on Invested Capital (ROIC)

-6.15%

Return on Capital Employed (ROCE)

-0.09

Revenue Per Employee

694.75K

Profits Per Employee

-1.08M

Employee Count

63

Asset Turnover

0.05

Inventory Turnover

1.18

The current PE Ratio of Shanghai Bio-Heart Biological Technology Co., Ltd. Class H is -2.68. Shanghai Bio-Heart Biological Technology Co., Ltd. Class H’s PEG ratio is -0.20.

PE Ratio

-2.68

PS Ratio

5.18

PB Ratio

0.50

Price to FCF

-2.49

Price to Operating Cash Flow

-2.93

PEG Ratio

-0.20

In the last 12 months, Shanghai Bio-Heart Biological Technology Co., Ltd. Class H had revenue of 43.77M and earned -68.24M in profits. Earnings per share was -0.28.

Revenue

43.77M

Gross Profit

-157.81K

Operating Income

-69.84M

Pretax Income

-93.52M

Net Income

-68.24M

EBITDA

-52.13M

Earnings Per Share (EPS)

-0.28

In the last 12 months, operating cash flow was -69.25M and capital expenditures -9.65M, giving a free cash flow of -78.90M billion.

Operating Cash Flow

-69.25M

Free Cash Flow

-78.90M

Free Cash Flow per Share

-0.32

Shanghai Bio-Heart Biological Technology Co., Ltd. Class H pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share

―

Dividend Yield

―

Payout Ratio

N/A

Free Cash Flow Yield

-40.33%

Earnings Yield

-36.80%

Beta

2.19

52-Week Price Change

-88.45%

50-Day Moving Average

1.49

200-Day Moving Average

3.19

Relative Strength Index (RSI)

17.37

Average Volume (3m)

120.90K

Shanghai Bio-Heart Biological Technology Co., Ltd. Class H upcoming earnings date is Mar 26, 2027, TBA (Not Confirmed).

Last Earnings Date

Aug 26, 2026

Next Earnings Date

Mar 26, 2027

Ex-Dividend Date

―

Shanghai Bio-Heart Biological Technology Co., Ltd. Class H as a current ratio of 15.26, with Debt / Equity ratio of 2.93%

Current Ratio

15.26

Quick Ratio

13.77

Debt to Market Cap

0.00

Net Debt to EBITDA

1.53

Interest Coverage Ratio

-8.20

In the past 12 months, Shanghai Bio-Heart Biological Technology Co., Ltd. Class H has paid -26.86M in taxes.

Income Tax

-26.86M

Effective Tax Rate

0.29

Shanghai Bio-Heart Biological Technology Co., Ltd. Class H EV to EBITDA ratio is -4.29, with an EV/FCF ratio of -3.60.

EV to Sales

7.50

EV to EBITDA

-4.29

EV to Free Cash Flow

-3.60

EV to Operating Cash Flow

-4.10

Shanghai Bio-Heart Biological Technology Co., Ltd. Class H has HKD 237.83M in cash and marketable securities with HKD 180.43M in debt, giving a net cash position of HKD 57.40M billion.

Cash & Marketable Securities

HKD 237.83M

Total Debt

HKD 180.43M

Net Cash

HKD 57.40M

Net Cash Per Share

HKD 0.24

Tangible Book Value Per Share

HKD 1.29

Gross margin is -2.29%, with operating margin of -228.91%, and net profit margin of -196.41%.

Gross Margin

-2.29%

Operating Margin

-228.91%

Pretax Margin

-265.15%

Net Profit Margin

-196.41%

EBITDA Margin

-174.70%

EBIT Margin

-228.91%

The average price target for Shanghai Bio-Heart Biological Technology Co., Ltd. Class H is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target

―

Price Target Upside

―

Analyst Consensus

―

Analyst Count

―

Revenue Growth Forecast

90.73%

EPS Growth Forecast

12.93%

Smart Score

2

AI Score

42